SAKAR HEALTHCARE
Back to Cashflow Statement
|
SAKAR HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹27 Cr | ₹41 Cr | ₹55 Cr | ₹32 Cr | ₹3.48 Cr |
What is the latest Cash Flow from Financing Activities ratio of SAKAR HEALTHCARE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹27 Cr |
Mar2023 | ₹41 Cr |
Mar2022 | ₹55 Cr |
Mar2021 | ₹32 Cr |
Mar2020 | ₹3.48 Cr |
How is Cash Flow from Financing Activities of SAKAR HEALTHCARE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹27 Cr | -33.22 | |
Mar2023 | ₹41 Cr | -24.76 | |
Mar2022 | ₹55 Cr | 70.51 | |
Mar2021 | ₹32 Cr | 820.22 | |
Mar2020 | ₹3.48 Cr | - |
Compare Cash Flow from Financing Activities of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹558.6 Cr | -11.4% | -12.3% | -36% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -11.4% |
-12.3% |
-36% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses